Factors that impact on recruitment to randomised trials in health care: a qualitative evidence synthesis.


Journal

The Cochrane database of systematic reviews
ISSN: 1469-493X
Titre abrégé: Cochrane Database Syst Rev
Pays: England
ID NLM: 100909747

Informations de publication

Date de publication:
07 Oct 2020
Historique:
entrez: 7 10 2020
pubmed: 8 10 2020
medline: 18 11 2020
Statut: epublish

Résumé

Randomised trials (also referred to as 'randomised controlled trials' or 'trials') are the optimal way to minimise bias in evaluating the effects of competing treatments, therapies and innovations in health care. It is important to achieve the required sample size for a trial, otherwise trialists may not be able to draw conclusive results leading to research waste and raising ethical questions about trial participation. The reasons why potential participants may accept or decline participation are multifaceted. Yet, the evidence of effectiveness of interventions to improve recruitment to trials is not substantial and fails to recognise these individual decision-making processes. It is important to synthesise the experiences and perceptions of those invited to participate in randomised trials to better inform recruitment strategies. To explore potential trial participants' views and experiences of the recruitment process for participation. The specific objectives are to describe potential participants' perceptions and experiences of accepting or declining to participate in trials, to explore barriers and facilitators to trial participation, and to explore to what extent barriers and facilitators identified are addressed by strategies to improve recruitment evaluated in previous reviews of the effects of interventions including a Cochrane Methodology Review. We searched the Cochrane Library, Medline, Embase, CINAHL, Epistemonikos, LILACS, PsycINFO, ORRCA, and grey literature sources. We ran the most recent set of searches for which the results were incorporated into the review in July 2017. We included qualitative and mixed-methods studies (with an identifiable qualitative component) that explored potential trial participants' experiences and perceptions of being invited to participate in a trial. We excluded studies that focused only on recruiters' perspectives, and trials solely involving children under 18 years, or adults who were assessed as having impaired mental capacity. Five review authors independently assessed the titles, abstracts and full texts identified by the search. We used the CART (completeness, accuracy, relevance, timeliness) criteria to exclude studies that had limited focus on the phenomenon of interest. We used QSR NVivo to extract and manage the data. We assessed methodological limitations using the Critical Skills Appraisal Programme (CASP) tool. We used thematic synthesis to analyse and synthesise the evidence. This provided analytical themes and a conceptual model. We used the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each finding. Our findings were integrated with two previous intervention effectiveness reviews by juxtaposing the quantitative and qualitative findings in a matrix. We included 29 studies (published in 30 papers) in our synthesis. Twenty-two key findings were produced under three broad themes (with six subthemes) to capture the experience of being invited to participate in a trial and making the decision whether to participate. Most of these findings had moderate to high confidence. We identified factors from the trial itself that influenced participation. These included how trial information was communicated, and elements of the trial such as the time commitment that might be considered burdensome. The second theme related to personal factors such as how other people can influence the individual's decision; and how a personal understanding of potential harms and benefits could impact on the decision. Finally, the potential benefits of participation were found to be key to the decision to participate, namely personal benefits such as access to new treatments, but also the chance to make a difference and help others. The conceptual model we developed presents the decision-making process as a gauge and the factors that influence whether the person will, or will not, take part. This qualitative evidence synthesis has provided comprehensive insight into the complexity of factors that influence a person's decision whether to participate in a trial. We developed key questions that trialists can ask when developing their recruitment strategy. In addition, our conceptual model emphasises the need for participant-centred approaches to recruitment. We demonstrated moderate to high level confidence in our findings, which in some way can be attributed to the large volume of highly relevant studies in this field. We recommend that these insights be used to direct or influence or underpin future recruitment strategies that are developed in a participant-driven way that ultimately improves trial conduct and reduces research waste.

Sections du résumé

BACKGROUND BACKGROUND
Randomised trials (also referred to as 'randomised controlled trials' or 'trials') are the optimal way to minimise bias in evaluating the effects of competing treatments, therapies and innovations in health care. It is important to achieve the required sample size for a trial, otherwise trialists may not be able to draw conclusive results leading to research waste and raising ethical questions about trial participation. The reasons why potential participants may accept or decline participation are multifaceted. Yet, the evidence of effectiveness of interventions to improve recruitment to trials is not substantial and fails to recognise these individual decision-making processes. It is important to synthesise the experiences and perceptions of those invited to participate in randomised trials to better inform recruitment strategies.
OBJECTIVES OBJECTIVE
To explore potential trial participants' views and experiences of the recruitment process for participation. The specific objectives are to describe potential participants' perceptions and experiences of accepting or declining to participate in trials, to explore barriers and facilitators to trial participation, and to explore to what extent barriers and facilitators identified are addressed by strategies to improve recruitment evaluated in previous reviews of the effects of interventions including a Cochrane Methodology Review.
SEARCH METHODS METHODS
We searched the Cochrane Library, Medline, Embase, CINAHL, Epistemonikos, LILACS, PsycINFO, ORRCA, and grey literature sources. We ran the most recent set of searches for which the results were incorporated into the review in July 2017.
SELECTION CRITERIA METHODS
We included qualitative and mixed-methods studies (with an identifiable qualitative component) that explored potential trial participants' experiences and perceptions of being invited to participate in a trial. We excluded studies that focused only on recruiters' perspectives, and trials solely involving children under 18 years, or adults who were assessed as having impaired mental capacity.
DATA COLLECTION AND ANALYSIS METHODS
Five review authors independently assessed the titles, abstracts and full texts identified by the search. We used the CART (completeness, accuracy, relevance, timeliness) criteria to exclude studies that had limited focus on the phenomenon of interest. We used QSR NVivo to extract and manage the data. We assessed methodological limitations using the Critical Skills Appraisal Programme (CASP) tool. We used thematic synthesis to analyse and synthesise the evidence. This provided analytical themes and a conceptual model. We used the GRADE-CERQual (Confidence in the Evidence from Reviews of Qualitative research) approach to assess our confidence in each finding. Our findings were integrated with two previous intervention effectiveness reviews by juxtaposing the quantitative and qualitative findings in a matrix.
MAIN RESULTS RESULTS
We included 29 studies (published in 30 papers) in our synthesis. Twenty-two key findings were produced under three broad themes (with six subthemes) to capture the experience of being invited to participate in a trial and making the decision whether to participate. Most of these findings had moderate to high confidence. We identified factors from the trial itself that influenced participation. These included how trial information was communicated, and elements of the trial such as the time commitment that might be considered burdensome. The second theme related to personal factors such as how other people can influence the individual's decision; and how a personal understanding of potential harms and benefits could impact on the decision. Finally, the potential benefits of participation were found to be key to the decision to participate, namely personal benefits such as access to new treatments, but also the chance to make a difference and help others. The conceptual model we developed presents the decision-making process as a gauge and the factors that influence whether the person will, or will not, take part.
AUTHORS' CONCLUSIONS CONCLUSIONS
This qualitative evidence synthesis has provided comprehensive insight into the complexity of factors that influence a person's decision whether to participate in a trial. We developed key questions that trialists can ask when developing their recruitment strategy. In addition, our conceptual model emphasises the need for participant-centred approaches to recruitment. We demonstrated moderate to high level confidence in our findings, which in some way can be attributed to the large volume of highly relevant studies in this field. We recommend that these insights be used to direct or influence or underpin future recruitment strategies that are developed in a participant-driven way that ultimately improves trial conduct and reduces research waste.

Identifiants

pubmed: 33026107
doi: 10.1002/14651858.MR000045.pub2
pmc: PMC8078544
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

MR000045

Subventions

Organisme : Chief Scientist Office
ID : HSRU1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Références

Trials. 2019 Aug 23;20(1):525
pubmed: 31443735
J Natl Compr Canc Netw. 2010 Dec;8(12):1343-51
pubmed: 21147901
J Clin Oncol. 2005 May 1;23(13):3112-24
pubmed: 15860871
Palliat Med. 2011 Dec;25(8):758-65
pubmed: 21844137
Int J Drug Policy. 2010 May;21(3):194-201
pubmed: 19482463
J Nerv Ment Dis. 2019 Jun;207(6):487-496
pubmed: 31158110
J Subst Abuse Treat. 2019 Apr;99:52-60
pubmed: 30797394
BMC Health Serv Res. 2016 Oct 19;16(1):589
pubmed: 27756285
BMC Med. 2017 Aug 15;15(1):155
pubmed: 28806964
BMC Med Ethics. 2014 Sep 20;15:68
pubmed: 25240404
Cochrane Database Syst Rev. 2019 Apr 15;4:CD010412
pubmed: 30982950
Nicotine Tob Res. 2014 Jan;16(1):42-9
pubmed: 23892826
Int J Orthop Trauma Nurs. 2016 Feb;20:3-12
pubmed: 26772763
Trials. 2012 Dec 10;13:237
pubmed: 23227880
J Adv Nurs. 2013 Jan;69(1):194-204
pubmed: 22591030
Sociol Health Illn. 2012 Jun;34(5):746-60
pubmed: 22118291
BMJ Open. 2019 Jan 15;9(1):e024224
pubmed: 30647042
Qual Saf Health Care. 2006 Apr;15(2):98-101
pubmed: 16585108
J Clin Epidemiol. 2018 May;97:49-58
pubmed: 29247700
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Clin Trials. 2010 Dec;7(6):696-704
pubmed: 20729253
J Med Ethics. 2007 Apr;33(4):234-40
pubmed: 17400624
Soc Sci Med. 2016 Jul;161:83-91
pubmed: 27261532
Soc Sci Med. 2002 Sep;55(5):709-19
pubmed: 12190265
BMJ. 2002 Oct 5;325(7367):766-70
pubmed: 12364308
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 27507437
J Empir Res Hum Res Ethics. 2011 Sep;6(3):31-8
pubmed: 21931235
Br J Gen Pract. 2003 May;53(490):394-8
pubmed: 12830569
Nurs Res. 2009 Nov-Dec;58(6):452-6
pubmed: 19918156
Am J Health Promot. 2015 May-Jun;29(5):332-8
pubmed: 24670073
Trials. 2006 Dec 12;7:32
pubmed: 17163988
BMJ Open. 2017 Mar 20;7(3):e015276
pubmed: 28320800
Trials. 2015 Sep 16;16:413
pubmed: 26377190
Eye (Lond). 2012 Feb;26(2):300-6
pubmed: 22094298
J Assoc Nurses AIDS Care. 2011 Jul-Aug;22(4):295-306
pubmed: 21256054
J Pain Symptom Manage. 2015 Apr;49(4):762-772.e5
pubmed: 25546286
Health Soc Work. 2013 Feb;38(1):29-38
pubmed: 23539894
Cochrane Database Syst Rev. 2020 Oct 7;10:MR000045
pubmed: 33026107
Int J Clin Pharm. 2018 Dec;40(6):1511-1518
pubmed: 30306454
Health Technol Assess. 2004 Oct;8(42):iii, 1-109
pubmed: 15488164
Br J Gen Pract. 2012 May;62(598):e371-7
pubmed: 22546597
Aging Clin Exp Res. 2020 Jan;32(1):133-140
pubmed: 30903598
Open Med. 2009;3(3):e123-30
pubmed: 21603045
Arthritis Rheum. 2007 Feb 15;57(1):49-55
pubmed: 17266094
Can J Surg. 2010 Jun;53(3):205-10
pubmed: 20507795
BMC Public Health. 2018 Apr 23;18(1):535
pubmed: 29685114
J Health Serv Res Policy. 2005 Jan;10(1):45-53
pubmed: 15667704
Glob Public Health. 2013 Jul;8(6):670-84
pubmed: 23826948
Syst Rev. 2016 May 04;5:74
pubmed: 27145932
Ethn Dis. 2012 Spring;22(2):226-30
pubmed: 22764647
PLoS Med. 2010 Sep 21;7(9):e1000326
pubmed: 20877712
J Cancer Educ. 2018 Feb;33(1):44-51
pubmed: 27392418
Trials. 2017 Mar 27;18(1):140
pubmed: 28347354
Trials. 2012 Nov 29;13:228
pubmed: 23190503
J Cancer Educ. 2016 Sep;31(3):421-9
pubmed: 26507744
Soc Sci Med. 2011 Jun;72(12):2041-8
pubmed: 21636195
Trials. 2016 Jul 20;17(1):329
pubmed: 27439472
Trials. 2018 Jun 22;19(1):327
pubmed: 29929536
J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):210-7
pubmed: 16394854
BMJ Open. 2017 Sep 11;7(9):e015201
pubmed: 28893742
Scand J Urol Nephrol. 2008;42(4):358-63
pubmed: 19230168
J Clin Epidemiol. 2018 May;97:70-78
pubmed: 29242095
Respir Med. 2007 Sep;101(9):1942-6
pubmed: 17540553
J Public Health (Oxf). 2011 Dec;33(4):604-15
pubmed: 21228023
Int Urogynecol J. 2013 Jun;24(6):969-75
pubmed: 23114890
Health Technol Assess. 2016 Feb;20(16):1-214
pubmed: 26931051
Cochrane Database Syst Rev. 2017 Nov 17;11:CD011558
pubmed: 29148566
BMC Public Health. 2010 May 28;10:292
pubmed: 20509908
Acta Oncol. 2007;46(1):49-59
pubmed: 17438705
PLoS Med. 2009 Oct;6(10):e1000148
pubmed: 19823568
Trials. 2018 Oct 25;19(1):584
pubmed: 30359293
Br J Psychiatry. 2015 Feb;206(2):122-7
pubmed: 25431429
BMJ Open. 2016 Dec 13;6(12):e012592
pubmed: 27965251
BMC Pregnancy Childbirth. 2019 Mar 20;19(1):97
pubmed: 30894167
Fam Pract. 2007 Dec;24(6):601-3
pubmed: 17872907
BMC Public Health. 2013 Jan 10;13:19
pubmed: 23302375
Contemp Clin Trials. 2009 Nov;30(6):552-9
pubmed: 19580887
Plast Reconstr Surg. 2011 Jul;128(1):305-310
pubmed: 21701348
BMC Fam Pract. 2013 Aug 28;14:125
pubmed: 23981474
BMC Geriatr. 2014 Apr 12;14:46
pubmed: 24725730
PLoS Med. 2016 Oct 18;13(10):e1002147
pubmed: 27755555
Emerg Med J. 2017 Sep;34(9):593-598
pubmed: 28500089
BMC Public Health. 2014 Aug 26;14:876
pubmed: 25159588
Trials. 2016 Oct 12;17(1):494
pubmed: 27733181
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
Health Expect. 2018 Dec;21(6):981-989
pubmed: 29655265
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Trials. 2016 Apr 01;17:178
pubmed: 27039181
BMC Public Health. 2013 Oct 28;13:1017
pubmed: 24165325
Implement Sci. 2018 Jan 25;13(Suppl 1):2
pubmed: 29384079
Res Nurs Health. 2007 Feb;30(1):99-111
pubmed: 17243111
Midwifery. 2012 Dec;28(6):800-8
pubmed: 22369926
Patient Educ Couns. 2004 Mar;52(3):341-8
pubmed: 14998605
J Clin Nurs. 2017 Mar;26(5-6):873-881
pubmed: 27324875
BMC Med Res Methodol. 2004 Apr 17;4:8
pubmed: 15090073
Qual Health Res. 2004 Dec;14(10):1342-65
pubmed: 15538004
Glob Health Promot. 2015 Mar;22(1):21-31
pubmed: 24842989
BMC Complement Altern Med. 2013 Oct 08;13:260
pubmed: 24103725
Ger Med Sci. 2015 Oct 14;13:Doc17
pubmed: 26512232
Acta Oncol. 2010 Aug;49(6):757-66
pubmed: 20515420
AJOB Prim Res. 2012;3(2):10-23
pubmed: 24748992
Trials. 2018 Aug 4;19(1):419
pubmed: 30075741
Health Technol Assess. 2007 Nov;11(48):iii, ix-105
pubmed: 17999843
Patient Educ Couns. 2002 Jan;46(1):31-8
pubmed: 11804767
Patient Educ Couns. 2011 Sep;84(3):303-9
pubmed: 21737226
Soc Sci Med. 2005 Oct;61(8):1854-65
pubmed: 15913858
Int J Nurs Stud. 2016 Sep;61:104-16
pubmed: 27343469
Support Care Cancer. 2014 May;22(5):1207-15
pubmed: 24362843
BMC Med Res Methodol. 2001;1:4
pubmed: 11423002
Bioethics. 2017 Jul;31(6):476-483
pubmed: 28608971
Alzheimer Dis Assoc Disord. 2016 Oct-Dec;30(4):338-344
pubmed: 27227995
BMJ Open. 2016 May 23;6(5):e011577
pubmed: 27217288
J Clin Epidemiol. 2018 May;97:35-38
pubmed: 29242094
BMC Med Res Methodol. 2006 Jul 19;6:34
pubmed: 16854229
BMC Womens Health. 2016 Jul 22;16:43
pubmed: 27449505
Trials. 2019 Aug 9;20(1):492
pubmed: 31399134
Perspect Clin Res. 2017 Jan-Mar;8(1):5-10
pubmed: 28194331
Cancer J. 2004 Sep-Oct;10(5):294-300
pubmed: 15530258
Contemp Clin Trials. 2012 Sep;33(5):925-32
pubmed: 22732312
BMC Pregnancy Childbirth. 2015 Sep 04;15:207
pubmed: 26341516
SAGE Open Med. 2015 Aug 10;3:2050312115596649
pubmed: 26770794
Contemp Clin Trials Commun. 2016 Dec 15;4:33-38
pubmed: 27458608
Cochrane Database Syst Rev. 2010 Apr 14;(4):MR000013
pubmed: 20393971
Cancer Nurs. 2007 Jul-Aug;30(4):261-9
pubmed: 17666974
Trials. 2010 Mar 22;11:31
pubmed: 20307273
JAMA. 2014 Mar 12;311(10):1045-51
pubmed: 24618966
Contemp Clin Trials. 2013 Jul;35(2):1-7
pubmed: 23591327
J Natl Med Assoc. 2002 Jul;94(7):609-18
pubmed: 12126287
Control Clin Trials. 2003 Jun;24(3):272-82
pubmed: 12757993
J Clin Epidemiol. 2007 Oct;60(10):990-1001
pubmed: 17884592
Health Technol Assess. 1999;3(20):1-143
pubmed: 10683591
J Pain Symptom Manage. 2015 Nov;50(5):642-649.e1
pubmed: 26031710
Evid Based Complement Alternat Med. 2016;2016:6495410
pubmed: 27956921
Trials. 2016 Sep 02;17(1):431
pubmed: 27590594
PLoS One. 2013 Dec 02;8(12):e81770
pubmed: 24312584
J Gynecol Obstet Biol Reprod (Paris). 2016 Nov;45(9):1054-1059
pubmed: 27114064
J Vasc Access. 2015 Sep-Oct;16(5):407-12
pubmed: 26349872
Can J Urol. 2005 Apr;12(2):2607-13
pubmed: 15877944
Cochrane Database Syst Rev. 2013 Oct 08;(10):CD010414
pubmed: 24101553
Trials. 2017 Sep 9;18(1):422
pubmed: 28886747
BMC Med Ethics. 2013 Oct 12;14:40
pubmed: 24119203
Patient Educ Couns. 2017 Feb;100(2):349-354
pubmed: 27578272
Trials. 2016 Jan 19;17:35
pubmed: 26787177
J Clin Med Res. 2014 Oct;6(5):384-7
pubmed: 25110544
BMC Health Serv Res. 2012 Jul 26;12:220
pubmed: 22834978
J Interprof Care. 2004 Nov;18(4):369-80
pubmed: 15801552
J Psychosom Obstet Gynaecol. 2018 Jun;39(2):112-120
pubmed: 28391738
Psychooncology. 2000 Jul-Aug;9(4):314-22
pubmed: 10960929
Acad Med. 2011 Nov;86(11):1360-6
pubmed: 21952064
Trials. 2011 Jan 11;12:7
pubmed: 21223551
Trials. 2006 Apr 07;7:9
pubmed: 16603070
West J Nurs Res. 2003 Mar;25(2):153-78
pubmed: 12666641
Cochrane Database Syst Rev. 2018 Feb 22;2:MR000013
pubmed: 29468635
Midwifery. 2012 Aug;28(4):E478-85
pubmed: 21944570
Trials. 2013 Jun 09;14:166
pubmed: 23758961
Pain Med. 2009 Jan;10(1):111-9
pubmed: 18657219
Trials. 2016 Apr 11;17:195
pubmed: 27066777
BMJ Open. 2012 Jan 06;2(1):e000496
pubmed: 22228729
J Empir Res Hum Res Ethics. 2016 Oct;11(4):299-310
pubmed: 28251864
Am J Public Health. 2014 Feb;104(2):e16-31
pubmed: 24328648
J Clin Epidemiol. 2018 Jul;99:41-52
pubmed: 29548841
Cochrane Database Syst Rev. 2017 Feb 07;2:CD011787
pubmed: 28169420
J Clin Epidemiol. 2011 Oct;64(10):1127-36
pubmed: 21477994
F1000Res. 2020 Feb 5;9:86
pubmed: 32685133
Trials. 2018 Jan 29;19(1):76
pubmed: 29378618
BMC Med Ethics. 2007 Aug 29;8:9
pubmed: 17727728
Trials. 2018 Sep 29;19(1):528
pubmed: 30268150
Health Technol Assess. 2015 Feb;19(11):1-138
pubmed: 25671821
J Clin Epidemiol. 1999 Dec;52(12):1143-56
pubmed: 10580777
J Adv Nurs. 2005 Apr;50(2):204-11
pubmed: 15788085
J Natl Med Assoc. 2001 Oct;93(10):392-401; discussion 402-4
pubmed: 11688920
Trials. 2014 Mar 29;15:98
pubmed: 24678918
Pilot Feasibility Stud. 2018 Nov 05;4:168
pubmed: 30410786
Eur J Cancer Care (Engl). 2011 Jul;20(4):445-54
pubmed: 20738392
Br Med J (Clin Res Ed). 1984 Nov 10;289(6454):1281-4
pubmed: 6437520

Auteurs

Catherine Houghton (C)

School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.

Maura Dowling (M)

School of Nursing and Midwifery, National University of Ireland, Galway, Galway, Ireland.

Pauline Meskell (P)

Department of Nursing and Midwifery, University of Limerick, Limerick, Ireland.

Andrew Hunter (A)

School of Nursing and Midwifery, National University of Ireland, Galway, Galway, Ireland.

Heidi Gardner (H)

Health Services Research Unit, University of Aberdeen, Aberdeen, UK.

Aislinn Conway (A)

School of Nursing and Midwifery, National University of Ireland, Galway, Galway, Ireland.

Shaun Treweek (S)

Health Services Research Unit, University of Aberdeen, Aberdeen, UK.

Katy Sutcliffe (K)

Department of Social Science, Social Science Research Unit, UCL Institute of Education, London, UK.

Jane Noyes (J)

Centre for Health-Related Research, Fron Heulog, Bangor University, Bangor, UK.

Declan Devane (D)

School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.

Jane R Nicholas (JR)

School of Nursing and Midwifery, National University of Ireland, Galway, Galway, Ireland.

Linda M Biesty (LM)

School of Nursing and Midwifery, National University of Ireland Galway, Galway, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH